Supercharged T-Cells Battle Cancer But Will GxP Compliance Be Their Kryptonite?
By Sheila G. Magil (smagilbptccom) What if your company had to sign off on hundreds of unique product batch releases a year; each a therapeutic for a specific individual, and where a “mix-up” could...
View ArticleQbD and Quality Systems Challenges Ahead as Cell Therapy Moves Forward
By David Broad As someone who worked on CAR-T cells and cell-based vaccines in the 1990’s, it was exciting to learn while attending the recent IBC Cell Therapy Bioprocessing and Commercialization...
View Article
More Pages to Explore .....